{
    "root": "c0a2c0db-d7c7-4d79-a8ce-13ed1e8fe36e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ALTUVIIIO",
    "value": "20250311",
    "ingredients": [],
    "indications": "altuviiio [ antihemophilic factor ( recombinant ) , fc-vwf-xten fusion protein-ehtl ] von willebrand factor ( vwf ) independent recombinant dna-derived , factor viii concentrate indicated adults children hemophilia ( congenital factor viii deficiency ) : routine prophylaxis reduce frequency bleeding episodes on-demand treatment control bleeding episodes perioperative management bleeding",
    "contraindications": "intravenous reconstitution .",
    "warningsAndPrecautions": null,
    "adverseReactions": "altuviiio contraindicated patients severe hypersensitivity , including anaphylaxis , product excipients [ description ( 11 ) ] .",
    "indications_original": "ALTUVIIIO [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is a von Willebrand Factor (VWF) independent recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:\n                  \n                     Routine prophylaxis to reduce the frequency of bleeding episodes\n                     On-demand treatment and control of bleeding episodes\n                     Perioperative management of bleeding",
    "contraindications_original": "For intravenous use after reconstitution only.",
    "adverseReactions_original": "ALTUVIIIO is contraindicated in patients who have had severe hypersensitivity reactions, including anaphylaxis, to the product or its excipients [see Description (11)]."
}